Press-release for stocks for bristol-myers squibb company for GLAXF

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.285 1.85% 1.6M

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
JNJ | News | $147.895 1.48% 5.8M

| -7.14% | O: 1.32% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
LLY | $727.48 -2.48% 2M

| -3.52% | O: 0.28% H: 1.71% C: -0.3%
BMY | $48.89 1.22% 5.1M

| -9.3% | O: 0.26% H: 2.03% C: 1.57%
AMGN | $267.41 1.77% 1.4M

| -7.46% | O: 0.54% H: 0.0% C: 0.0%
antibody research global

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 510

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $138.24 800

| 0.45% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.285 1.85% 1.6M

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.89 1.22% 5.1M

| -9.3% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $165.97 0.8% 3.1M

| -8.42% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $106.76 1.42% 3.8M

| -5.06% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -8.47% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.41 0.07% 2.9M

| 0.01% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $267.41 1.77% 1.4M

| -7.46% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 510

| -3.76% | O: -2.33% H: 3.68% C: 2.44%
NVSEF | $93.6375 6.88% 82K

| -7.38% | O: 0.89% H: 0.0% C: 0.0%
NVS | $94.285 1.85% 1.6M

| -7.81% | O: 1.03% H: 0.14% C: 0.05%
JNJ | News | $147.895 1.48% 5.8M

| -10.18% | O: 0.28% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| -5.49% | O: 0.26% H: 0.18% C: 0.05%
BMY | $48.89 1.22% 5.1M

| -4.83% | O: 0.37% H: 0.27% C: -0.1%
integration reach momentum infection treatment market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 510

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $138.24 800

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 7.2K

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 520K

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.19 0.23% 740K

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.285 1.85% 1.6M

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.585 0.8% 1.1M

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | $727.48 -2.48% 2M

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.89 1.22% 5.1M

| -5.13% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $165.97 0.8% 3.1M

| -6.33% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.545 2.55% 2.3M

| -3.44% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.41 0.07% 2.9M

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $267.41 1.77% 1.4M

| -6.54% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $138.24 800

| 12.13% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.47 520K

| -13.68% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.19 0.23% 740K

| -8.11% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.285 1.85% 1.6M

| -7.41% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $147.895 1.48% 5.8M

| -7.44% | O: 0.7% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| -3.58% | O: 1.22% H: 0.07% C: -0.43%
LLY | $727.48 -2.48% 2M

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.89 1.22% 5.1M

| -2.91% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $165.97 0.8% 3.1M

| -4.57% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | News | $14.115 -0.74% 110K

| -25.59% | O: -1.15% H: 1.03% C: -1.5%
VRTX | News | $395.0 0.39% 550K

| -5.63% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.545 2.55% 2.3M

| -1.49% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.35 3.8K

| -8.91% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.07 -1.42% 800K

| -8.68% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $193.75 1.7% 1M

| -20.26% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.41 0.07% 2.9M

| 11.16% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $359.51 0.31% 280K

| -5.61% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $267.41 1.77% 1.4M

| -10.02% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 510

| 2.46% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K

| -6.6% | O: 1.8% H: 0.0% C: -1.82%
NVS | $94.285 1.85% 1.6M

| -13.0% | O: 0.29% H: 0.15% C: -0.13%
JNJ | News | $147.895 1.48% 5.8M

| -8.89% | O: 0.8% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| 1.96% | O: 1.36% H: 0.23% C: -0.76%
BMY | $48.89 1.22% 5.1M

| -2.64% | O: 0.71% H: 0.48% C: -0.52%
ABBV | News | $165.97 0.8% 3.1M

| 0.76% | O: 0.85% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -8.8% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

Global Urinary Tract Infection (UTI) Treatment Market is expected to Reach US$ 13,617.4 million by 2034, rising at a 1.9% CAGR- FMI Study
Published: 2024-01-22 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 510

| 0.5% | O: -2.34% H: 0.43% C: 0.43%
JNJ | News | $147.895 1.48% 5.8M

| -10.5% | O: -1.11% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| 0.18% | O: -0.76% H: 0.38% C: 0.13%
BMY | $48.89 1.22% 5.1M

| -2.56% | O: 0.22% H: 1.49% C: 0.89%
expected million reach infection treatment global study market

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | $138.24 800

| -0.76% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $147.895 1.48% 5.8M

| -10.38% | O: 0.52% H: 0.57% C: -0.56%
GSK | $39.585 0.8% 1.1M

| 4.02% | O: -0.5% H: 0.26% C: -0.69%
LLY | $727.48 -2.48% 2M

| 30.85% | O: -1.47% H: 0.0% C: 0.0%
BMY | $48.89 1.22% 5.1M

| -17.83% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $165.97 0.8% 3.1M

| 7.43% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $46.545 2.55% 2.3M

| -17.87% | O: -1.16% H: 0.0% C: 0.0%
AZN | $68.41 0.07% 2.9M

| 0.45% | O: 0.19% H: 0.03% C: -1.57%
AMGN | $267.41 1.77% 1.4M

| -2.4% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence Market Research
Published: 2023-09-18 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 510

| 9.19% | O: 2.7% H: 0.0% C: -5.11%
GSK | $39.585 0.8% 1.1M

| 5.8% | O: 0.72% H: 0.13% C: -0.93%
BMY | $48.89 1.22% 5.1M

| -18.18% | O: 0.02% H: 0.18% C: -0.78%
ABBV | News | $165.97 0.8% 3.1M

| 8.2% | O: 0.33% H: 0.0% C: 0.0%
BIIB | $193.75 1.7% 1M

| -23.41% | O: 0.06% H: 0.44% C: -0.64%
treatment research market

Global Orphan Drugs Market Analysis Report 2023: A 229.71 Billion Market by 2026 - Therapeutic Versatility and the Impacts on Oncology, Hematology, and More
Published: 2023-09-15 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 510

| 13.36% | O: 3.82% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| 10.49% | O: 0.79% H: 0.0% C: 0.0%
NVS | $94.285 1.85% 1.6M

| -8.59% | O: 1.51% H: 0.26% C: -0.72%
JNJ | News | $147.895 1.48% 5.8M

| -11.48% | O: 0.15% H: 0.51% C: -1.54%
GSK | $39.585 0.8% 1.1M

| 5.91% | O: 0.83% H: 0.27% C: -0.72%
LLY | $727.48 -2.48% 2M

| 26.9% | O: 0.08% H: 0.0% C: 0.0%
BMY | $48.89 1.22% 5.1M

| -18.81% | O: -0.08% H: 0.65% C: -0.69%
ABBV | News | $165.97 0.8% 3.1M

| 7.5% | O: -0.64% H: 0.0% C: 0.0%
report global market

Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published: 2023-09-09 (Crawled : 04:20) - prnewswire.com
VTRS | $11.21 0.81% 2.4M

| Email alert Add to watchlist
GSK | $39.585 0.8% 1.1M

| Email alert Add to watchlist
BMY | $48.89 1.22% 5.1M

| Email alert Add to watchlist
GILD | News | $66.45 0.44% 4.3M

| Email alert Add to watchlist
ABBV | News | $165.97 0.8% 3.1M

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
JNJ | News | $147.895 1.48% 5.8M

| Email alert Add to watchlist
report antiviral therapeutics market

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 510

| 11.2% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -16.61% | O: -0.95% H: 0.19% C: -0.32%
PFE A | $25.91 2.05% 22M

| -31.09% | O: 0.19% H: 0.11% C: -1.46%
NVS | $94.285 1.85% 1.6M

| -6.46% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $147.895 1.48% 5.8M

| -11.42% | O: 0.03% H: 0.12% C: -0.24%
GSK | $39.585 0.8% 1.1M

| 9.18% | O: -0.91% H: 0.56% C: -0.5%
LLY | $727.48 -2.48% 2M

| 65.82% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.89 1.22% 5.1M

| -25.45% | O: -0.06% H: 0.46% C: 0.0%
AZN | $68.41 0.07% 2.9M

| -4.83% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | $138.24 800

| -7.89% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | $93.6375 6.88% 82K

| 14.25% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.19 0.23% 740K

| -18.27% | O: -0.62% H: 0.88% C: 0.81%
NVS | $94.285 1.85% 1.6M

| -5.5% | O: 1.26% H: 1.08% C: 0.91%
GSK | $39.585 0.8% 1.1M

| 15.25% | O: 0.41% H: 0.68% C: 0.64%
LLY | $727.48 -2.48% 2M

| 72.05% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.89 1.22% 5.1M

| -25.87% | O: 0.28% H: 0.42% C: -0.05%
BNTX | $87.13 1.11% 350K

| -21.24% | O: 0.39% H: 0.15% C: -0.79%
AZN | $68.41 0.07% 2.9M

| -6.88% | O: -0.23% H: 1.83% C: 1.52%
AMGN | $267.41 1.77% 1.4M

| 19.74% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published: 2023-05-31 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 510

| 21.03% | O: -0.24% H: 2.1% C: 2.1%
VTRS | $11.21 0.81% 2.4M

| 21.53% | O: 0.0% H: 0.66% C: 0.33%
TEVA | $12.905 0.98% 5.9M

| 83.06% | O: 0.42% H: 0.83% C: -0.41%
JNJ | News | $147.895 1.48% 5.8M

| -6.52% | O: -0.34% H: 0.32% C: 0.0%
GSK | $39.585 0.8% 1.1M

| 17.86% | O: -0.24% H: 1.43% C: 0.84%
BMY | $48.89 1.22% 5.1M

| -25.05% | O: 0.03% H: 0.41% C: 0.34%
ABBV | News | $165.97 0.8% 3.1M

| 19.72% | O: -1.96% H: 0.0% C: -1.35%
ABT | News | $106.76 1.42% 3.8M

| 4.31% | O: -0.09% H: 0.97% C: 0.89%
GILD | News | $66.45 0.44% 4.3M

| -13.05% | O: 0.78% H: 0.0% C: -1.72%
report treatment global hiv therapy growth market

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 50

| -10.86% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $86.918 60K

| -11.33% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $138.24 800

| 3.92% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $543.895 0.44% 830K

| -4.57% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $12.905 0.98% 5.9M

| 33.0% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.19 0.23% 740K

| -15.92% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $30.625 2.29% 640K

| -18.72% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.585 0.8% 1.1M

| 14.95% | O: 0.32% H: 0.17% C: -1.53%
LLY | $727.48 -2.48% 2M

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.82 0.04% 740K

| -21.81% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.89 1.22% 5.1M

| -29.9% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $112.52 0.64% 1.3M

Process Industries

| -55.43% | O: -0.95% H: 1.02% C: -2.19%
ABBV | News | $165.97 0.8% 3.1M

| 6.36% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $46.545 2.55% 2.3M

| -4.65% | O: 0.65% H: 0.0% C: 0.0%
GILD | News | $66.45 0.44% 4.3M

| -17.52% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $193.75 1.7% 1M

| -27.79% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.41 0.07% 2.9M

| 5.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

Global Personalized Medicines Strategic Market Report 2023: Market to Surpass $740 Billion by 2030 - Genomics to Dictate Advancement of Personalized Medicines
Published: 2023-02-17 (Crawled : 04:00) - prnewswire.com
TMO | News | $543.895 0.44% 830K

| -4.41% | O: -0.84% H: 1.55% C: 1.23%
NVS | $94.285 1.85% 1.6M

| 8.28% | O: -0.24% H: 1.61% C: 1.52%
GSK | $39.585 0.8% 1.1M

| 12.69% | O: 0.54% H: 1.6% C: 1.56%
BMY | $48.89 1.22% 5.1M

| -31.83% | O: -0.32% H: 1.59% C: 0.69%
HOLX | $75.265 0.22% 470K

| -9.32% | O: 0.1% H: 0.31% C: 0.04%
global report genomics market

Myelofibrosis Treatment Market to Reach $1.16 Billion, Globally, by 2031 at 4.0% CAGR: Allied Market Research
Published: 2023-02-06 (Crawled : 12:00) - prnewswire.com
GLAXF | $20.2 510

| 16.16% | O: 2.88% H: 1.17% C: -2.24%
GSK | $39.585 0.8% 1.1M

| 13.7% | O: 1.64% H: 0.24% C: -0.17%
BMY | $48.89 1.22% 5.1M

| -35.12% | O: 0.0% H: 0.98% C: 0.11%
AMRX | $5.37 0.19% 500K

| 120.58% | O: 0.0% H: 6.58% C: 4.53%
ABBV | News | $165.97 0.8% 3.1M

| 13.75% | O: 0.37% H: 0.4% C: -0.49%
INCY | $52.07 -1.42% 800K

| -36.83% | O: 0.0% H: 1.47% C: 0.9%
GLTO | $0.72 46K

| -73.43% | O: -1.11% H: 3.36% C: 1.12%
treatment research market

Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published: 2023-01-27 (Crawled : 13:20) - prnewswire.com
GLAXF | $20.2 510

| 16.76% | O: 1.13% H: 1.57% C: 1.57%
JNJ | News | $147.895 1.48% 5.8M

| -14.17% | O: -0.21% H: 0.19% C: -0.18%
GSK | $39.585 0.8% 1.1M

| 12.05% | O: -0.03% H: 0.3% C: -0.08%
BMY | $48.89 1.22% 5.1M

| -33.83% | O: 0.0% H: 0.63% C: -0.74%
ABBV | News | $165.97 0.8% 3.1M

| 12.05% | O: -0.06% H: 0.25% C: -0.7%
research global antiviral market

Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 510

| 14.14% | O: 0.69% H: 0.0% C: -1.52%
SNYNF | News | $92.7 600K

| -4.71% | O: 1.26% H: 1.19% C: 1.19%
TAK | News | $13.19 0.23% 740K

| -18.53% | O: -0.31% H: 1.15% C: 0.68%
NVO | $122.69 -0.05% 3.8M

| -10.9% | O: 0.13% H: 0.65% C: 0.51%
NVS | $94.285 1.85% 1.6M

| 1.0% | O: -0.1% H: 0.31% C: 0.17%
JNJ | News | $147.895 1.48% 5.8M

| -14.61% | O: -0.43% H: 1.33% C: 0.3%
GSK | $39.585 0.8% 1.1M

| 12.53% | O: 0.17% H: 1.36% C: 1.02%
LLY | $727.48 -2.48% 2M

| 113.28% | O: 0.1% H: 0.97% C: -0.37%
BMY | $48.89 1.22% 5.1M

| -33.05% | O: 0.29% H: 2.1% C: 1.94%
ABBV | News | $165.97 0.8% 3.1M

| 10.7% | O: -0.17% H: 1.07% C: -0.16%
SNY | News | $46.545 2.55% 2.3M

| -8.54% | O: -0.92% H: 0.0% C: 0.0%
GILD | News | $66.45 0.44% 4.3M

| -20.11% | O: 0.51% H: 0.49% C: -0.65%
AMGN | $267.41 1.77% 1.4M

| 0.21% | O: -0.9% H: 0.58% C: 0.01%
global report growth market

Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published: 2023-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 510

| 15.03% | O: -1.77% H: 0.75% C: 0.75%
GSK | $39.585 0.8% 1.1M

| 13.05% | O: -1.28% H: 0.35% C: -0.29%
LLY | $727.48 -2.48% 2M

| 106.77% | O: -0.59% H: 0.15% C: -0.56%
BMY | $48.89 1.22% 5.1M

| -33.49% | O: -1.21% H: 0.89% C: 0.25%
ABBV | News | $165.97 0.8% 3.1M

| 0.9% | O: -0.37% H: 0.86% C: 0.25%
SNY | News | $46.545 2.55% 2.3M

| -7.59% | O: -3.07% H: 0.0% C: 0.0%
global active report teva market

← Previous
1
2
3
Next →

Gainers vs Losers

70%

30%

Top 10 Gainers

AGBA | News | $1.305 226.25% 130M

Finance

EGOX | $0.0503 39.72% 320M

RWOD | $10.52 31.56% 5.9M

ZCMD | $1.905 31.38% 30M

Commercial Services

MRDB 4 | $0.536 27.65% 2M

BSFC | $0.0822 27.64% 75M

TPET | $0.4121 25.68% 45M

NVFY | $2.65 25.59% 33M

Consumer Durables

INDO | $5.1 25.0% 15M

Energy Minerals

CHRO | $1.53 24.9% 100K